Jubilant Ingrevia Limited — Updates, 05-02-2026: Press Release

Jubilant Ingrevia reported Q3 revenue of ₹1,051 Cr (-1% YoY), EBITDA of ₹136 Cr (-8% YoY), and PAT of ₹47 Cr (-32% YoY). Nine-month results showed growth. The board declared an interim dividend of ₹2.5/share. Specialty Chemicals maintained strong margins despite pricing pressure, with a robust CDMO pipeline. Capex continues for future growth.